Literature DB >> 20959805

Tyrosine dephosphorylation is required for Bak activation in apoptosis.

Joanna L Fox1, Ferina Ismail, Abul Azad, Nicola Ternette, Sabrina Leverrier, Mariola J Edelmann, Benedikt M Kessler, Irene M Leigh, Sarah Jackson, Alan Storey.   

Abstract

Activation of the cell-death mediator Bak commits a cell to mitochondrial apoptosis. The initial steps that govern Bak activation are poorly understood. To further clarify these pivotal events, we have investigated whether post-translational modifications of Bak impinge on its activation potential. In this study, we report that on apoptotic stimulation Bak undergoes dephosphorylation at tyrosine residue 108 (Y108), a critical event that is necessary but not sufficient for Bak activation, but is required both for early exposure of the occluded N-terminal domain and multimerisation. RNA interference (RNAi) screening identified non-receptor tyrosine phosphatases (PTPNs) required for Bak dephosphorylation and apoptotic induction through chemotherapeutic agents. Specifically, modulation of PTPN5 protein expression by siRNA and overexpression directly affected both Bak-Y108 phosphorylation and the initiation of Bak activation. We further show that MEK/ERK signalling directly affects Bak phosphorylation through inhibition of PTPN5 to promote cell survival. We propose a model of Bak activation in which the regulation of Bak dephosphorylation constitutes the initial step in the activation process, which reveals a previously unsuspected mechanism controlling the initiation of mitochondrial apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20959805      PMCID: PMC2989102          DOI: 10.1038/emboj.2010.244

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  63 in total

1.  Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins.

Authors:  Jerry E Chipuk; John C Fisher; Christopher P Dillon; Richard W Kriwacki; Tomomi Kuwana; Douglas R Green
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-12       Impact factor: 11.205

2.  To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions.

Authors:  Grant Dewson; Tobias Kratina; Huiyan W Sim; Hamsa Puthalakath; Jerry M Adams; Peter M Colman; Ruth M Kluck
Journal:  Mol Cell       Date:  2008-05-09       Impact factor: 17.970

3.  Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma.

Authors:  Chun Feng Lee; Zhi Qiang Ling; Ting Zhao; Shih Hua Fang; Weng Cheng Chang; San Chih Lee; Kuan Rong Lee
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

Review 4.  Diagnosing and exploiting cancer's addiction to blocks in apoptosis.

Authors:  Anthony G Letai
Journal:  Nat Rev Cancer       Date:  2008-02       Impact factor: 60.716

5.  Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation.

Authors:  Ozgur Kutuk; Elif Damla Arisan; Tugsan Tezil; Maria C Shoshan; Huveyda Basaga
Journal:  Carcinogenesis       Date:  2009-07-03       Impact factor: 4.944

6.  Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain.

Authors:  E Christine Pietsch; Erin Perchiniak; Adrian A Canutescu; Guoli Wang; Roland L Dunbrack; Maureen E Murphy
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

7.  Novel dimerization mode of the human Bcl-2 family protein Bak, a mitochondrial apoptosis regulator.

Authors:  Hongfei Wang; Chie Takemoto; Ryogo Akasaka; Tomomi Uchikubo-Kamo; Seiichiro Kishishita; Kazutaka Murayama; Takaho Terada; Lirong Chen; Zhi-Jie Liu; Bi-Cheng Wang; Sumio Sugano; Akiko Tanaka; Makoto Inoue; Takanori Kigawa; Mikako Shirouzu; Shigeyuki Yokoyama
Journal:  J Struct Biol       Date:  2008-12-24       Impact factor: 2.867

Review 8.  Tumour cell survival signalling by the ERK1/2 pathway.

Authors:  K Balmanno; S J Cook
Journal:  Cell Death Differ       Date:  2008-10-10       Impact factor: 15.828

9.  BAX activation is initiated at a novel interaction site.

Authors:  Evripidis Gavathiotis; Motoshi Suzuki; Marguerite L Davis; Kenneth Pitter; Gregory H Bird; Samuel G Katz; Ho-Chou Tu; Hyungjin Kim; Emily H-Y Cheng; Nico Tjandra; Loren D Walensky
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

10.  Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability.

Authors:  Sebastian Korff; Stefan M Woerner; Yan P Yuan; Peer Bork; Magnus von Knebel Doeberitz; Johannes Gebert
Journal:  BMC Cancer       Date:  2008-11-10       Impact factor: 4.430

View more
  24 in total

1.  MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex.

Authors:  M Konopleva; M Milella; P Ruvolo; J C Watts; M R Ricciardi; B Korchin; T McQueen; W Bornmann; T Tsao; P Bergamo; D H Mak; W Chen; J McCubrey; A Tafuri; M Andreeff
Journal:  Leukemia       Date:  2011-11-08       Impact factor: 11.528

Review 2.  Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis.

Authors:  D Westphal; R M Kluck; G Dewson
Journal:  Cell Death Differ       Date:  2013-10-25       Impact factor: 15.828

3.  "Licensed to kill": tyrosine dephosphorylation and Bak activation.

Authors:  Joanna Fox; Abul Azad; Ferina Ismail; Alan Storey
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

Review 4.  Mitochondrial phosphorylation in apoptosis: flipping the death switch.

Authors:  Natalie M Niemi; Jeffrey P MacKeigan
Journal:  Antioxid Redox Signal       Date:  2012-12-07       Impact factor: 8.401

5.  The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim.

Authors:  Lazaro E Aira; Elodie Villa; Pascal Colosetti; Parvati Gamas; Laurie Signetti; Sandrine Obba; Emma Proics; Fabien Gautier; Béatrice Bailly-Maitre; Arnaud Jacquel; Guillaume Robert; Frédéric Luciano; Philippe P Juin; Jean-Ehrland Ricci; Patrick Auberger; Sandrine Marchetti
Journal:  Oncogene       Date:  2018-02-02       Impact factor: 9.867

Review 6.  Role of Notch signaling pathway in pancreatic cancer.

Authors:  Jiankun Gao; Bo Long; Zhiwei Wang
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

Review 7.  Evading apoptosis in cancer.

Authors:  Kaleigh Fernald; Manabu Kurokawa
Journal:  Trends Cell Biol       Date:  2013-08-16       Impact factor: 20.808

Review 8.  Mitochondria-Judges and Executioners of Cell Death Sentences.

Authors:  Patrick D Bhola; Anthony Letai
Journal:  Mol Cell       Date:  2016-03-03       Impact factor: 17.970

9.  BMX Negatively Regulates BAK Function, Thereby Increasing Apoptotic Resistance to Chemotherapeutic Drugs.

Authors:  Joanna L Fox; Alan Storey
Journal:  Cancer Res       Date:  2015-02-03       Impact factor: 12.701

10.  BAK multimerization for apoptosis, but not bid binding, is inhibited by negatively charged residue in the BAK hydrophobic groove.

Authors:  Abul Azad; Alan Storey
Journal:  Mol Cancer       Date:  2013-06-19       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.